British Columbia Investment Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
SGA
EIP
British Columbia Investment Management's CLB Position: Q4 2017 in Review
British Columbia Investment Management sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 17,917 shares — an estimated $1.77M sold.
British Columbia Investment Management first reported a position in CLB in Q2 2013 and held it in 18 quarters. The position peaked at $7.52M in Q1 2016. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.
- British Columbia Investment Management reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
- British Columbia Investment Management sold 17,917 Core Laboratories shares in Q4 2017, an estimated $1.77M.
- British Columbia Investment Management first reported a position in Core Laboratories in Q2 2013 and held it in 18 quarters.
- British Columbia Investment Management's Core Laboratories position peaked at $7.52M in Q1 2016.
- 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.
Based on British Columbia Investment Management's 13F filing for Q4 2017, filed 20 Feb 2018.